| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.07e-03 | 61 | 16 | 2 | GO:1901682 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 1.62e-05 | 65 | 16 | 3 | GO:0072348 | |
| HumanPheno | Abnormal dense granules | 7.73e-05 | 9 | 8 | 2 | HP:0012484 | |
| HumanPheno | Abnormal platelet granules | 1.67e-04 | 13 | 8 | 2 | HP:0011883 | |
| MousePheno | abnormal platelet ADP level | 9.65e-06 | 7 | 10 | 2 | MP:0009556 | |
| MousePheno | decreased platelet ADP level | 9.65e-06 | 7 | 10 | 2 | MP:0009557 | |
| MousePheno | abnormal platelet ATP level | 2.07e-05 | 10 | 10 | 2 | MP:0009447 | |
| MousePheno | decreased platelet ATP level | 2.07e-05 | 10 | 10 | 2 | MP:0009448 | |
| MousePheno | decreased susceptibility to atherosclerosis | 2.52e-05 | 11 | 10 | 2 | MP:0005341 | |
| MousePheno | decreased ear pigmentation | 3.03e-05 | 12 | 10 | 2 | MP:0011279 | |
| MousePheno | abnormal choroid pigmentation | 4.17e-05 | 14 | 10 | 2 | MP:0005100 | |
| MousePheno | decreased cellular ATP level | 5.50e-05 | 16 | 10 | 2 | MP:0014246 | |
| MousePheno | decreased platelet serotonin level | 5.50e-05 | 16 | 10 | 2 | MP:0004725 | |
| MousePheno | abnormal platelet serotonin level | 5.50e-05 | 16 | 10 | 2 | MP:0004723 | |
| MousePheno | abnormal cellular ATP level | 6.23e-05 | 17 | 10 | 2 | MP:0014244 | |
| MousePheno | decreased tail pigmentation | 7.00e-05 | 18 | 10 | 2 | MP:0011277 | |
| MousePheno | impaired balance | 7.26e-05 | 121 | 10 | 3 | MP:0001525 | |
| MousePheno | abnormal susceptibility to atherosclerosis | 7.83e-05 | 19 | 10 | 2 | MP:0005340 | |
| MousePheno | decreased eye pigmentation | 1.16e-04 | 23 | 10 | 2 | MP:0005172 | |
| MousePheno | abnormal platelet dense granule morphology | 1.37e-04 | 25 | 10 | 2 | MP:0004721 | |
| MousePheno | abnormal ear pigmentation | 1.48e-04 | 26 | 10 | 2 | MP:0000015 | |
| MousePheno | abnormal outer ear skin morphology | 1.60e-04 | 27 | 10 | 2 | MP:0030530 | |
| MousePheno | abnormal foot pigmentation | 1.72e-04 | 28 | 10 | 2 | MP:0009379 | |
| MousePheno | abnormal iris pigmentation | 2.12e-04 | 31 | 10 | 2 | MP:0005102 | |
| MousePheno | abnormal head skin morphology | 2.55e-04 | 34 | 10 | 2 | MP:0030529 | |
| MousePheno | abnormal extracutaneous pigmentation | 2.60e-04 | 186 | 10 | 3 | MP:0009389 | |
| MousePheno | abnormal foam cell morphology | 2.76e-04 | 954 | 10 | 5 | MP:0009840 | |
| MousePheno | abnormal tail pigmentation | 3.37e-04 | 39 | 10 | 2 | MP:0005174 | |
| MousePheno | decreased serotonin level | 3.54e-04 | 40 | 10 | 2 | MP:0010070 | |
| MousePheno | abnormal vestibular system physiology | 5.32e-04 | 49 | 10 | 2 | MP:0004742 | |
| MousePheno | abnormal optic choroid morphology | 5.99e-04 | 52 | 10 | 2 | MP:0005098 | |
| MousePheno | hypopigmentation | 6.22e-04 | 53 | 10 | 2 | MP:0005408 | |
| MousePheno | abnormal sperm number | 6.66e-04 | 624 | 10 | 4 | MP:0002673 | |
| MousePheno | decreased male germ cell number | 7.33e-04 | 640 | 10 | 4 | MP:0004901 | |
| MousePheno | increased susceptibility to Herpesvirales infection | 8.24e-04 | 61 | 10 | 2 | MP:0020916 | |
| MousePheno | abnormal melanocyte morphology | 8.24e-04 | 61 | 10 | 2 | MP:0002877 | |
| MousePheno | diluted coat color | 9.07e-04 | 64 | 10 | 2 | MP:0000371 | |
| MousePheno | decreased germ cell number | 9.57e-04 | 687 | 10 | 4 | MP:0002209 | |
| MousePheno | abnormal serotonin level | 1.18e-03 | 73 | 10 | 2 | MP:0005322 | |
| MousePheno | impaired swimming | 1.41e-03 | 80 | 10 | 2 | MP:0001522 | |
| MousePheno | abnormal susceptibility to Herpesvirales infection | 1.52e-03 | 83 | 10 | 2 | MP:0020915 | |
| MousePheno | abnormal gametes | 1.58e-03 | 785 | 10 | 4 | MP:0001124 | |
| MousePheno | abnormal cerebellar granule layer morphology | 1.59e-03 | 85 | 10 | 2 | MP:0000886 | |
| MousePheno | abnormal skin pigmentation | 1.67e-03 | 87 | 10 | 2 | MP:0002095 | |
| MousePheno | increased bleeding time | 1.82e-03 | 91 | 10 | 2 | MP:0005606 | |
| MousePheno | small testis | 1.88e-03 | 823 | 10 | 4 | MP:0001147 | |
| MousePheno | oligozoospermia | 2.14e-03 | 384 | 10 | 3 | MP:0002687 | |
| MousePheno | abnormal male germ cell morphology | 2.20e-03 | 859 | 10 | 4 | MP:0006362 | |
| MousePheno | small gonad | 2.46e-03 | 885 | 10 | 4 | MP:0001116 | |
| MousePheno | abnormal primary sex determination | 2.63e-03 | 901 | 10 | 4 | MP:0002211 | |
| MousePheno | abnormal spermatogenesis | 2.73e-03 | 910 | 10 | 4 | MP:0001156 | |
| MousePheno | abnormal testis size | 2.78e-03 | 915 | 10 | 4 | MP:0004849 | |
| MousePheno | abnormal outer ear morphology | 3.09e-03 | 119 | 10 | 2 | MP:0002177 | |
| MousePheno | abnormal sex determination | 3.13e-03 | 945 | 10 | 4 | MP:0002210 | |
| MousePheno | abnormal germ cell morphology | 3.15e-03 | 946 | 10 | 4 | MP:0002208 | |
| MousePheno | abnormal urine homeostasis | 3.71e-03 | 466 | 10 | 3 | MP:0009643 | |
| MousePheno | abnormal ear morphology | 3.80e-03 | 470 | 10 | 3 | MP:0002102 | |
| MousePheno | abnormal retina pigment epithelium morphology | 3.96e-03 | 135 | 10 | 2 | MP:0005201 | |
| MousePheno | arrest of male meiosis | 4.25e-03 | 140 | 10 | 2 | MP:0008261 | |
| MousePheno | abnormal retina layer morphology | 4.63e-03 | 504 | 10 | 3 | MP:0003727 | |
| MousePheno | abnormal gametogenesis | 4.93e-03 | 1070 | 10 | 4 | MP:0001929 | |
| Domain | Cadherin_tail | 4.50e-04 | 37 | 16 | 2 | PF15974 | |
| Domain | Cadherin_CBD | 4.50e-04 | 37 | 16 | 2 | IPR031904 | |
| Domain | Cadherin_N | 1.39e-03 | 65 | 16 | 2 | IPR013164 | |
| Domain | Cadherin_2 | 1.39e-03 | 65 | 16 | 2 | PF08266 | |
| Domain | Cadherin_CS | 3.84e-03 | 109 | 16 | 2 | IPR020894 | |
| Domain | Cadherin | 4.12e-03 | 113 | 16 | 2 | PF00028 | |
| Domain | CADHERIN_1 | 4.12e-03 | 113 | 16 | 2 | PS00232 | |
| Domain | - | 4.19e-03 | 114 | 16 | 2 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 4.19e-03 | 114 | 16 | 2 | PS50268 | |
| Domain | CA | 4.26e-03 | 115 | 16 | 2 | SM00112 | |
| Domain | Cadherin-like | 4.34e-03 | 116 | 16 | 2 | IPR015919 | |
| Domain | Cadherin | 4.48e-03 | 118 | 16 | 2 | IPR002126 | |
| Domain | AAA+_ATPase | 6.60e-03 | 144 | 16 | 2 | IPR003593 | |
| Domain | AAA | 6.60e-03 | 144 | 16 | 2 | SM00382 | |
| Domain | WD40_repeat_dom | 2.61e-02 | 297 | 16 | 2 | IPR017986 | |
| Domain | - | 3.23e-02 | 333 | 16 | 2 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.26e-02 | 335 | 16 | 2 | IPR015943 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.02e-03 | 108 | 9 | 2 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.06e-03 | 109 | 9 | 2 | MM15074 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 2.49e-03 | 120 | 9 | 2 | MM14585 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 2.82e-03 | 128 | 9 | 2 | M706 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 6.49e-03 | 196 | 9 | 2 | MM14591 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 7.49e-03 | 211 | 9 | 2 | M649 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 9.45e-03 | 238 | 9 | 2 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.03e-02 | 249 | 9 | 2 | M5988 | |
| Pubmed | Analysis of atherosclerosis susceptibility in mice with genetic defects in platelet function. | 1.98e-06 | 5 | 16 | 2 | 2369371 | |
| Pubmed | 2.08e-05 | 15 | 16 | 2 | 15640798 | ||
| Pubmed | 2.08e-05 | 15 | 16 | 2 | 6696991 | ||
| Pubmed | 2.69e-05 | 17 | 16 | 2 | 29911975 | ||
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 3.02e-05 | 18 | 16 | 2 | 10662547 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 3.02e-05 | 18 | 16 | 2 | 15570159 | |
| Pubmed | 5.44e-05 | 24 | 16 | 2 | 24698270 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 7.45e-05 | 28 | 16 | 2 | 15347688 | |
| Pubmed | 8.93e-05 | 193 | 16 | 3 | 22589738 | ||
| Pubmed | 1.10e-04 | 34 | 16 | 2 | 33500475 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 3.12e-04 | 57 | 16 | 2 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 3.23e-04 | 58 | 16 | 2 | 30377227 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 4.44e-04 | 68 | 16 | 2 | 11230163 | |
| Cytoband | 5q31 | 7.29e-04 | 115 | 16 | 2 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q42 | 3.11e-03 | 240 | 16 | 2 | chr1q42 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 4.75e-03 | 298 | 16 | 2 | chr5q31 | |
| GeneFamily | Phospholipases | 4.71e-04 | 42 | 14 | 2 | 467 | |
| GeneFamily | Clustered protocadherins | 1.09e-03 | 64 | 14 | 2 | 20 | |
| GeneFamily | Solute carriers | 3.15e-03 | 395 | 14 | 3 | 752 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-05 | 186 | 16 | 3 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.92e-05 | 189 | 16 | 3 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-05 | 189 | 16 | 3 | bd91bdfe35294e60d980259b70fe9e60dca2743f | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 190 | 16 | 3 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-05 | 190 | 16 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.52e-05 | 15 | 15 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 9.72e-05 | 29 | 15 | 2 | EFO_0008009 | |
| Disease | visceral adipose tissue measurement, body mass index | 8.80e-04 | 87 | 15 | 2 | EFO_0004340, EFO_0004765 | |
| Disease | unipolar depression | 2.64e-03 | 1206 | 15 | 4 | EFO_0003761 | |
| Disease | Myocardial Ischemia | 3.53e-03 | 176 | 15 | 2 | C0151744 | |
| Disease | neutrophil count, basophil count | 5.64e-03 | 224 | 15 | 2 | EFO_0004833, EFO_0005090 | |
| Disease | Drugs used in diabetes use measurement | 7.25e-03 | 255 | 15 | 2 | EFO_0009924 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LWKVWTELLDVLGLD | 91 | Q8WY22 | |
| TEEKWNWLLLLEIDL | 426 | Q09MP3 | |
| WLNLELLLPVIIDCW | 76 | Q8NCC3 | |
| LLEWELVVLGKLKWN | 136 | P30279 | |
| MDLLWILPSLWLLLL | 1 | O75636 | |
| WIPETVEEWKLLLHL | 1021 | Q9UPZ3 | |
| ARDLLLWLLLLAAWE | 11 | Q9Y5I3 | |
| PRQLLLWLLILAAWE | 11 | Q9Y5I0 | |
| WEGKLLLLQEILDEW | 966 | Q8WXX0 | |
| VKLLEELLLDWKIWS | 1911 | Q99698 | |
| LALTLEALPWVLRWL | 16 | Q8N2A8 | |
| EILEVILSEWWLKEP | 1101 | Q5TCS8 | |
| LKWDLALCLLLVWLV | 216 | P31641 | |
| LLLLPEEWDVWLIKL | 371 | Q8IY50 | |
| ILEWLPKYRVKEWLL | 71 | O43511 | |
| LELISQLKWVELPWL | 216 | Q8TF39 | |
| QLKWVELPWLLEEVS | 221 | Q8TF39 |